Low dose methylprednisolone induced bradycardia

Area of Science:

• Cardiology
• Pharmacology
• Internal Medicine

Background:

• Methylprednisolone is a corticosteroid with known cardiac side effects.
• Arrhythmias, particularly bradycardia, are documented adverse events associated with methylprednisolone therapy.
• Existing literature primarily links these arrhythmias to high-dose intravenous administration.

Observation:

• This report details a patient experiencing bradycardia.
• The bradycardia was observed in the context of low-dose methylprednisolone administration.
• This contrasts with the typical association of methylprednisolone-induced arrhythmias with high-dose therapy.

Findings:

• Low-dose methylprednisolone can induce bradycardia.
• This finding expands the known spectrum of methylprednisolone-related cardiac adverse events.
• The case suggests a potential for cardiac side effects even at lower therapeutic levels.

Implications:

• Clinicians should be vigilant for bradycardia in patients receiving even low doses of methylprednisolone.
• This case may prompt a re-evaluation of the dose-dependency of methylprednisolone-induced arrhythmias.
• Further research may be warranted to understand the mechanisms and prevalence of low-dose methylprednisolone-induced bradycardia.